Measuring adherence to inhaled control medication in patients with asthma: Comparison among an asthma app, patient self-report and physician assessment

Data de publicação:

Autores da FMUP

  • Ana Margarida Barbosa Ribeiro Pereira

    Autor

  • Rute Alexandra Borges De Almeida

    Autor

  • Rita Da Silva Amaral

    Autor

  • Pedro Manuel Vieira Marques

    Autor

  • Rosália Cristina Gabriel Páscoa

    Autor

  • Diana Margarida Gonçalves Solha Pereira Da Silva

    Autor

  • Susana Maria Gouveia Fernandes

    Autor

  • João De Almeida Lopes Da Fonseca

    Autor

  • Cristina Isabel Oliveira Jácome

    Autor

Participantes de fora da FMUP

  • Cachim, A
  • Alves-Correia, M
  • Chaves-Loureiro, C
  • Ribeiro, C
  • Cardia, F
  • Gomes, J
  • Vidal, C
  • Silva, E
  • Rocha, S
  • Rocha, D
  • Marques, ML
  • Morais, D
  • Cruz, AM
  • Santalha, M
  • Simoes, JA
  • da Silva, S
  • Gerardo, R
  • Bom, FT
  • Morete, A
  • Vieira, I
  • Vieira, P
  • Monteiro, R
  • Raimundo, MR
  • Monteiro, L
  • Neves, A
  • Santos, C
  • Penas, AM
  • Regadas, R
  • Marques, JV
  • Rosendo, I
  • Aguiar, MA
  • Cardoso, CS
  • Pimenta, F
  • Meireles, P
  • Gonçalves, M

Unidades de investigação

Abstract

BackgroundPrevious studies have demonstrated the feasibility of using an asthma app to support medication management and adherence but failed to compare with other measures currently used in clinical practice. However, in a clinical setting, any additional adherence measurement must be evaluated in the context of both the patient and physician perspectives so that it can also help improve the process of shared decision making. Thus, we aimed to compare different measures of adherence to asthma control inhalers in clinical practice, namely through an app, patient self-report and physician assessment. MethodsThis study is a secondary analysis of three prospective multicentre observational studies with patients (>= 13 years old) with persistent asthma recruited from 61 primary and secondary care centres in Portugal. Patients were invited to use the InspirerMundi app and register their inhaled medication. Adherence was measured by the app as the number of doses taken divided by the number of doses scheduled each day and two time points were considered for analysis: 1-week and 1-month. At baseline, patients and physicians independently assessed adherence to asthma control inhalers during the previous week using a Visual Analogue Scale (VAS 0-100). ResultsA total of 193 patients (72% female; median [P25-P75] age 28 [19-41] years old) were included in the analysis. Adherence measured by the app was lower (1 week: 31 [0-71]%; 1 month: 18 [0-48]%) than patient self-report (80 [60-95]) and physician assessment (82 [51-94]) (p < 0.001). A negligible non-significant correlation was found between the app and subjective measurements (rho 0.118-0.156, p > 0.05). There was a moderate correlation between patient self-report and physician assessment (rho = 0.596, p < 0.001). ConclusionsAdherence measured by the app was lower than that reported by the patient or the physician. This was expected as objective measurements are commonly lower than subjective evaluations, which tend to overestimate adherence. Nevertheless, the low adherence measured by the app may also be influenced by the use of the app itself and this needs to be considered in future studies.

© 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

Dados da publicação

ISSN/ISSNe:
2045-7022, 2045-7022

Clinical and Translational Allergy  John Wiley &amp; Sons Inc.

Tipo:
Article
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Scopus: 3

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • asthma; clinical decision support systems; eHealth; medication adherence; mHealth; mobile apps; patient participation; self-management; smartphone; technology assessment

Financiamento

Proyectos asociados

Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021

Effect of a Mobile App on Improving Asthma Control in Adolescents and Adults With Persistent Asthma: A Pilot Randomized Multicentre, Superiority Clinical Trial (mINSPIRERS) - NCT05129527

Investigador Principal: João de Almeida Lopes da Fonseca

Ensaio Clínico Académico (mINSPIRERS) . 2021

Virtual Shared Medical Appointments in Lifestyle Approach for Type 2 Diabetes: Protocol of a Randomized Pragmatic Trial (SMAs) - NCT05279326

Investigador Principal: Rosália Cristina Gabriel Páscoa

Ensaio Clínico Académico (SMAs) . 2022

Molecular Allergen Based Diagnosis Impact on Clinical Efficacy of Aeroallergen Immunotherapy- a Pragmatic Randomized Clinical Trial (CRD-AIT) - NCT05448066

Investigador Principal: Diana Margarida Gonçalves Solha Pereira da Silva

Ensaio Clínico Académico (CRD-AIT) . SP Alergologia Imunologia Clinica . 2022

Utilização em estudos observacionais do Registo de Asma Grave Portugal.

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Observacional Académico (RAG) . 2020

Clinical Research Collaboration Severe Heterogenous Asthma Research collaboration, Patient-centered (CRC SHARP).

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Observacional (SHARP) . European Respiratory Society . 2021

Multidimensional phenotyping of severe asthma patients and its impact on disease control and therapeutic response - analysis from the Portuguese Severe Asthma Registry.

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Observacional (RAG-SPP-GSK) . SPPneumologia . 2022

BREATHE - An oBservational, pRimary data study to characterize severe AsThma pHenotypes and assEss disease burden across the EUCAN region.

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Observacional (RAG-AZ-BREATHE) . AstraZeneca . 2022

Efficiency in Spine Care ? Assessing outcomes and costs to inform healthcare improvement

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2022

Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação